<![CDATA[Crucell N.V. | Company News & Executive Profiles | BNET]]> en-us <![CDATA[DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins]]> Tue, 10 Feb 2009 23:59:59 -0800 <![CDATA[DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6® Cell Line Proteins]]> Tue, 10 Feb 2009 23:59:59 -0800 <![CDATA[Crucell Announces Profits for Full Year 2008]]> Thu, 05 Feb 2009 23:59:59 -0800 <![CDATA[Crucell to Release Q4 & FY 2008 Results on Thursday, February 5, 2009]]> Wed, 04 Feb 2009 23:59:59 -0800 <![CDATA[Discussions on a Combination of Crucell and Wyeth Discontinued]]> Mon, 26 Jan 2009 23:59:59 -0800 WYE WYE <![CDATA[Crucell and Wyeth in Discussion on a Combination of the Two Companies]]> Wed, 07 Jan 2009 23:59:59 -0800 WYE WYE <![CDATA[DSM and Crucell Announce PER.C6(R) Research License Agreement with GSK]]> Thu, 18 Dec 2008 23:59:59 -0800 <![CDATA[DSM and Crucell Announce PER.C6(R) License Agreement with CSL Ltd.]]> Thu, 18 Dec 2008 23:59:59 -0800 <![CDATA[Crucell Signs Second Exclusive License Agreement with Talecris Biotherapeutics]]> Wed, 17 Dec 2008 23:59:59 -0800 <![CDATA[DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter]]> Tue, 25 Nov 2008 23:59:59 -0800